Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$2.08−0.01 (-0.48%)
Close on Nov 16, 2026Market cap $35.46MP/E –Yield –
Veru gross margin
Gross margin is gross profit as a percentage of revenue.
Veru's gross margin for the twelve months ending Sep 30, 2024 was 34.7%. For fiscal 2024 it was 34.7%, against 46.4% the year before. The highest annual figure on record is 53138.6% in fiscal 2011.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | 34.7% | −11.8 |
| FY2023 | Sep 30, 2023 | 46.4% | −31.3 |
| FY2022 | Sep 30, 2022 | 77.7% | −0.5 |
| FY2021 | Sep 30, 2021 | 78.2% | +6.0 |
| FY2020 | Sep 30, 2020 | 72.3% | +4.2 |
| FY2019 | Sep 30, 2019 | 68.1% | +12.8 |
| FY2018 | Sep 30, 2018 | 55.3% | +3.9 |
| FY2017 | Sep 30, 2017 | 51.4% | −8.9 |
| FY2016 | Sep 30, 2016 | 60.3% | +2.1 |
| FY2015 | Sep 30, 2015 | 58.2% | +4.6 |
| FY2014 | Sep 30, 2014 | 53.6% | −2.1 |
| FY2013 | Sep 30, 2013 | 55.6% | −3.2 |
| FY2012 | Sep 30, 2012 | 58.9% | −53079.8 |
| FY2011 | Sep 30, 2011 | 53138.6% | +53080.5 |
| FY2010 | Sep 30, 2010 | 58.2% | +9.1 |
| FY2009 | Sep 30, 2009 | 49.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | 40.4% | +0.5 |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | 33.8% | −3.0 |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | 16.4% | −45.7 |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | 53.7% | +25.7 |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | 39.9% | +20.4 |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | 36.8% | −36.8 |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | 62.1% | −23.6 |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | 28.0% | −55.8 |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | 19.5% | −59.1 |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | 73.6% | −5.0 |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | 85.8% | +4.0 |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | 83.8% | +9.6 |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | 78.7% | −2.7 |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | 78.6% | +15.4 |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | 81.8% | +7.0 |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | 74.1% | +5.4 |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | 81.4% | +14.6 |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | 63.2% | −4.4 |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | 74.8% | +8.7 |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | 68.7% | −4.2 |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | 66.8% | +5.6 |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | 67.6% | +11.7 |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | 66.1% | +19.5 |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | 72.9% | +22.1 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | 61.2% | +12.6 |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | 55.9% | +2.7 |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | 46.6% | −6.6 |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | 50.8% | −0.2 |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | 48.6% | −3.8 |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | 53.2% | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | 53.1% | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | 50.9% | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | 52.4% | – |
See a number that looks wrong?